Pharmaceutical Investing Theratechnologies Receives Positive Recommendation From the CHMP for Trogarzo® in the European Union
European Medicines Agency validates Oasmia Pharmaceutical AB’s application to add efficacy data to the approved Apealea
Pharmaceutical Investing European CHMP Adopts Positive Opinion for Yescarta (axicabtagene ciloleucel)
Pharmaceutical Investing Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo (nivolumab)
Significant intercepts of gold and copper show Golden Eye emerging as a highly promising new resource prospect
Alvopetro Announces an Operational Update, Q1 2025 Financial Results and Details for our Upcoming AGM
Grande Portage Stakes Added Claims to Accommodate Potential Surface Facilities at the New Amalga Gold Project
